APHD · Verde Bio Holdings, Inc. · Financials
$1.13
At close · Oct 2
Return incl. dividend (before tax)
Going-concern doubt
— flagged Mar 25, 2024
Substantial doubt about the company's ability to continue as a going concern.
“These factors raise substantial doubt regarding the Company's ability to continue as a going concern for a period of one year from the date these financial statements were issued, or March 25, 2024.”View the 10-Q filed Mar 25, 2024
Market Cap
$2.59B
Shares
2.02B
Volume · Oct 2
1529
Avg daily vol (9 sessions)
329
Income-statement, balance-sheet and cash-flow figures from SEC filings, plus a debt profile anchored in the latest 10-K and updated by each 10-Q and debt exhibit.
Revenue
$0
-100%
FY2019
Net Income
-$1.86M
+45.9%
FY2023
Gross Margin
44.27%
-11.8pp
FY2018
Operating Margin
-1077.18%
-170.4pp
FY2018
Diluted EPS
-$0.01
-94.3%
FY2020
Operating Cash Flow
-$872.23K
+24.2%
FY2023
Chart any reported metric, KPI or segment over time — the full statement history lives here
Search above to add metrics — fundamentals, product and segment revenue, company KPIs, valuation.
| Line Item | TTM | FY2023 | FY2022 | FY2021 | FY2020 | FY2019 | FY2018 | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| — | — | — | — | — | $0 | $41.85K | $50.3K | $2725 | $258 | $485 | $689 | $1544 | $6025 | |
| — | — | — | — | — | — | — | — | — | — | — | — | -$369 | -$2236 | |
| — | — | — | — | — | $0 | $23.32K | $22.12K | $1821 | — | — | — | — | — | |
| — | — | — | -$1665 | $0 | $0 | $18.53K | $28.19K | $904 | — | — | — | — | — | |
| — | — | — | — | — | — | 44.27% | 56.04% | 33.17% | — | — | — | — | — | |
| — | — | — | — | — | $14.01K | $88.02K | $78.64K | $16.72K | $56.56K | -$2040 | $13.41K | $23.49K | $43.98K | |
| $15.48K | $87.46K | $25.87K | $0 | $0 | — | — | — | — | — | $255 | $445 | $601 | $501 | |
| $1.79M | $2.57M | $3.87M | $3.01M | $259.22K | $37.08K | $469.33K | $484.31K | $197.21K | $233.77K | $134.97K | $161.53K | $153.04K | $133.14K | |
| -$1.44M | -$1.64M | -$3.15M | -$2.97M | -$259.22K | -$37.08K | -$450.8K | -$456.13K | -$196.31K | -$233.52K | -$134.49K | -$160.84K | -$151.5K | — | |
| — | — | — | — | — | — | -1077.18% | -906.74% | -7203.93% | -90510.08% | -27729.69% | -23343.83% | -9811.98% | — | |
| — | -$1.55M | -$3.12M | -$2.97M | -$259.22K | — | — | — | — | — | -$134.23K | -$160.39K | -$150.9K | — | |
| $37.68K | $65.88K | $0 | $366.06K | $231.66K | $350.33K | $299.33K | $181.68K | $19.66K | $133.15K | $3953 | — | $369 | — | |
| -$1.14M | -$134.25K | -$272.03K | -$348.93K | -$1.32M | -$500.01K | -$1.04M | -$1.67M | $70.67K | -$564.35K | -$270.31K | $40K | — | — | |
| — | -$1.77M | -$3.42M | -$3.32M | -$1.58M | -$537.09K | -$1.5M | -$2.12M | -$125.64K | -$797.87K | -$404.8K | -$143.53K | -$145.49K | -$127.39K | |
| — | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | $0 | — | — | — | |
| -$2.69M | -$1.86M | -$3.44M | $0 | -$1.58M | -$537.09K | -$1.5M | -$2.12M | -$125.64K | -$797.87K | -$404.8K | -$120.84K | -$145.49K | -$129.35K | |
| — | — | — | — | — | — | -3572.29% | -4219.86% | -4610.57% | -309250% | -83464.33% | -17538.32% | -9423.12% | -2146.92% | |
| — | — | — | — | — | — | -$1.5M | -$2.07M | — | — | — | — | — | — | |
| USD/shares | — | — | — | — | -$0.01 | -$0.01 | — | — | — | — | — | — | — | — |
| shares | — | — | 113.94B | 9.48B | 153.33M | 101.81M | 1.47B | 69.76M | 1.26B | 80.24M | 7.39M | 896.11M | 739.27M | — |
| shares | 1.86B | — | 113.94B | 9.48B | 153.33M | 101.81M | 1.47B | 69.76M | 1.26B | 80.24M | 7.39M | 896.11M | 739.27M | — |
Italic rows are computed from reported lines — open a row's info icon for its formula. Values reflect the latest filing (restatements included); per-share figures on today's split basis. Click a value for its source filing.
TTM: trailing twelve months through the latest reported quarter — flows sum the last four quarters, balances take the latest. 3Y/5Y/10Y columns are trailing CAGR from the newest fiscal year; blank where an endpoint is missing or negative.
Debt Profile
Reported borrowing balances, repayment dates and agreement terms, with links to the underlying filings.
Reported debt balances
Each amount keeps its reported scope. Related balance-sheet measures appear under the borrowing they describe.
| Reported balance | As of | Amount | Source |
|---|---|---|---|
| Current portion of convertible notes payable | 2024-01-31 | USD 65,167 | 10-Q filed 2024-03-25 |
Instrument and agreement coverage is incomplete. Additional filings are awaiting review.
Covenants
Covenant terms have not yet been verified for this profile.
The balance figures do not establish whether covenants apply or whether the company complies with them.
Loans, facilities and notes
The instrument breakdown is not yet verified. Read the debt note in the linked report for borrowing terms and maturity conditions.